Activity of ceftazidime (GR 20263) against nosocomially important pathogens.
AUTOR(ES)
Hamilton-Miller, J M
RESUMO
Ceftazidime was considerably more active than cefuroxime against 180 strains of resistant species of nosocomial gram-negative bacteria. In terms of antibacterial spectrum and intrinsic activity, ceftazidime is an improvement upon existing beta-lactam antibiotics in clinical use and can be regarded as a possible alternative to gentamicin.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=181609Documentos Relacionados
- Activity of Ceftazidime (GR 20263) Against Nosocomially Important Pathogens
- Activity of temafloxacin against respiratory pathogens.
- Activity of ciprofloxacin against genital tract pathogens.
- Intracellular activity of azithromycin against bacterial enteric pathogens.
- In vitro activity of azithromycin against bacterial enteric pathogens.
